Yale Scleroderma Program — New Haven, Connecticut

Yale Scleroderma Program is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Yale Scleroderma Program has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Systemic Sclerosis (SSc), Calcinosis Cutis.

Sponsors: Yale University.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale Scleroderma Program?

Yale Scleroderma Program has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale Scleroderma Program conducted?

Yale Scleroderma Program has 1 clinical trials on record, with 1 currently active. Their work covers Systemic Sclerosis (SSc), Calcinosis Cutis.

Is Yale Scleroderma Program accredited by Crixeo Health?

Yale Scleroderma Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale Scleroderma Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.